Skip to main content
OpenTrials
Completed

NCT Number: NCT00845754

Post-Operative Treatment With Ketorolac After Abdominal Myomectomy

The purpose of this study is to determine if ketorolac, given after abdominal myomectomy, will decrease the frequency of post-oerative fevers as well as improve post-operative pain management.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Columbia University Medical Center

New York, 10032, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Ant patient undregoing abdominal myomectomy

Exclusion criteria

  • Patients with contraindication to NSAIDs including history of peptic ulcer disease, renal disease, bleeding diathesis, or hypersensitivity to NSAIDS

Treatment and study plan

Ketorolac

Drug

15mg IV every6 hours for 4doses

Other names: Toradol

Saline

Drug

15mg IV every 6hrs for 4 doses

Primary outcomes

  1. Post-operative febrile morbidity

    Time frame: Inital 24hrs post-operative

Secondary outcomes

  1. Post-operative pain management

    Time frame: Initial 24hrs post-operative

Sponsors and collaborators

Lead sponsor

Ascher-Walsh, Charles, M.D.

Indiv

Collaborators

  • Icahn School of Medicine at Mount Sinai
  • New York Presbyterian Hospital

Registry information

Official study title

Effects of Ketorolac on Post-Operative Febrile Morbidity and Pain Management in Abdominal Myomectomy Patients

Important dates

Study start
1999
Primary completion
2001
Study completion
2001
First posted
Feb 18, 2009
Registry last updated
Feb 18, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.